Publication | Open Access
Comparative Study of Bezafibrate and Pravastatin in Patients With Coronary Artery Disease and High Levels of Remnant Lipoprotein
20
Citations
25
References
2010
Year
Bezafibrate therapy decreased RLP-C levels to a greater extent than pravastatin and a decrease in RLP-C level may be associated with a reduction in CV events in patients with high RLP-C levels.
| Year | Citations | |
|---|---|---|
Page 1
Page 1